High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03474562

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03474562
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03474562. Randomized; no masking; primary purpose treatment. Start 2018-04-03 (actual); primary completion 2019-06-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension
Condition
ASCVD
Condition
Impaired Fasting Glucose
Condition
Hypertension
Intervention (Drug)
Duowell®
Intervention (Drug)
Monorova® + Amlopin®
Lead sponsor
Yuhan Corporation (class: industry)

Record details

Record id
cardio:ct-nct03474562
Content hash
3fa4cc5ba984cec0f59512d1bde6ab612d8f054cd4e0a881b4a2eeb8a128a3d9